by Tyler Silcox | Apr 5, 2023 | In the News
The latest Medicare guidance will stifle pharmaceutical innovation—and it’s worse than we thought.The Biden administration has issued guidance on how it will implement the Medicare drug price controls in the Inflation Reduction Act. The controls will be far-reaching...
by Tyler Silcox | Mar 31, 2023 | Weekly Newsletter
Trump indictment: What we know and what happens next The Hill: Former President Trump’s indictment by a Manhattan grand jury has sent the political and legal worlds into a frenzy. Here’s what we know so far about the case against Trump and what could happen next...
by Tyler Silcox | Mar 31, 2023 | Weekly Newsletter
Trump indictment: What we know and what happens next The Hill: Former President Trump’s indictment by a Manhattan grand jury has sent the political and legal worlds into a frenzy. Here’s what we know so far about the case against Trump and what could happen next...
by Tyler Silcox | Mar 28, 2023 | Press Releases
Rep. Barry Loudermilk (R-GA), Chairman of the Committee on House Administration Subcommittee on Oversight, issued the following statement as it pertains to the subcommittee’s initial findings after reviewing some of the documents obtained from the former Select...
by Tyler Silcox | Mar 25, 2023 | Weekly Newsletter
Video: Financial Services Committee: Battling the Fentanyl Crisis In the News: House Republicans launch their version of Jan. 6 committee, probing “misconduct” by original panel DISTRICT UPDATE Click here if you have trouble viewing this email...
